{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:54:38Z","timestamp":1776380078275,"version":"3.51.2"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"S3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW Fortschr Med"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s15006-026-5739-8","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:01:31Z","timestamp":1776376891000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u00dcbersicht zur Relevanz der intestinalen  Mukusschicht der Darmbarriere","Overview of the relevance of the intestinal  mucus layer of the intestinal barrier \u2013 current state of knowledge and clinical perspective"],"prefix":"10.1007","volume":"168","author":[{"given":"Martin","family":"Storr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Burghard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"5739_CR2596","doi-asserted-by":"crossref","unstructured":"Acker WW et al. Prevalence of food allergies and intolerances documented in electronic health records. J Allergy Clin Immunol. 2017;140(6):1587\u201391 e1","DOI":"10.1016\/j.jaci.2017.04.006"},{"key":"5739_CR2600","doi-asserted-by":"crossref","unstructured":"Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712\u201321 e4","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"5739_CR2604","doi-asserted-by":"crossref","unstructured":"Layer P et al. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft f\u00fcr Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft f\u00fcr Neurogastroenterologie und Motilit\u00e4t (DGNM). Z Gastroenterol. 2021;59(12):1323\u2013415","DOI":"10.1055\/a-1646-1349"},{"key":"5739_CR2608","doi-asserted-by":"crossref","unstructured":"Parrish A et al. Intestinal mucus barrier: a missing piece of the puzzle in food allergy. Trends Mol Med. 2022;28(1):36\u201350","DOI":"10.1016\/j.molmed.2021.10.004"},{"key":"5739_CR2612","doi-asserted-by":"crossref","unstructured":"Shan Y et al. The gut microbiome and inflammatory bowel diseases. Annu Rev Med. 2022;73:455\u201368","DOI":"10.1146\/annurev-med-042320-021020"},{"key":"5739_CR2616","doi-asserted-by":"crossref","unstructured":"Miyauchi E et al. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat Rev Immunol. 2023;23(1):9\u201323","DOI":"10.1038\/s41577-022-00727-y"},{"key":"5739_CR2429","doi-asserted-by":"crossref","unstructured":"Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy partners? Gut. 2020;69(12):2232\u201343","DOI":"10.1136\/gutjnl-2020-322260"},{"key":"5739_CR2622","doi-asserted-by":"crossref","unstructured":"Raygoza Garay JA et al. Gut microbiome composition is associated with future onset of Crohn's disease in healthy first-degree relatives. Gastroenterology. 2023;165(3):670\u201381","DOI":"10.1053\/j.gastro.2023.05.032"},{"key":"5739_CR2435","doi-asserted-by":"crossref","unstructured":"Johansson MEV et al. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut. 2014;63(2):281\u201391","DOI":"10.1136\/gutjnl-2012-303207"},{"key":"5739_CR2423","doi-asserted-by":"crossref","unstructured":"Van Hul M et al. What defines a healthy gut microbiome? Gut. 2024;73(11):1893\u2013908","DOI":"10.1136\/gutjnl-2024-333378"},{"key":"5739_CR2638","doi-asserted-by":"crossref","unstructured":"Fusco W et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota. Nutrients. 2023;15(9):2211","DOI":"10.3390\/nu15092211"},{"key":"5739_CR2642","doi-asserted-by":"crossref","unstructured":"Duncan SH et al. Lactate-utilizing bacteria, isolated from human feces, that produce butyrate as a major fermentation product. Appl Environ Microbiol. 2004;70(10):5810\u20137","DOI":"10.1128\/AEM.70.10.5810-5817.2004"},{"key":"5739_CR2646","doi-asserted-by":"crossref","unstructured":"Amaretti A et al. Profiling of protein degraders in cultures of human gut microbiota. Front Microbiol. 2019;10:2614","DOI":"10.3389\/fmicb.2019.02614"},{"key":"5739_CR2650","doi-asserted-by":"crossref","unstructured":"Postler TS, Ghosh S. Understanding the holobiont: how microbial metabolites affect human health and shape the immune system. Cell Metab. 2017;26(1):110\u201330","DOI":"10.1016\/j.cmet.2017.05.008"},{"key":"5739_CR2439","doi-asserted-by":"crossref","unstructured":"Camilleri M et al. Intestinal barrier function in health and gastrointestinal disease. Neurogastroenterol Motil. 2012;24(6):503\u201312","DOI":"10.1111\/j.1365-2982.2012.01921.x"},{"key":"5739_CR2443","doi-asserted-by":"crossref","unstructured":"Tokuhara D et al. A comprehensive understanding of the gut mucosal immune system in allergic inflammation. Allergol Int. 2019;68(1):17\u201325","DOI":"10.1016\/j.alit.2018.09.004"},{"key":"5739_CR2676","doi-asserted-by":"crossref","unstructured":"Desai MS et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell. 2016;167(5):1339\u201353 e21","DOI":"10.1016\/j.cell.2016.10.043"},{"key":"5739_CR2680","doi-asserted-by":"crossref","unstructured":"Salvi PS, Cowles RA. Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease. Cells. 2021;10(7):1775","DOI":"10.3390\/cells10071775"},{"key":"5739_CR2684","doi-asserted-by":"crossref","unstructured":"Burger-van Paassen N et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids: implications for epithelial protection. Biochem J. 2009;420(2):211\u20139","DOI":"10.1042\/BJ20082222"},{"key":"5739_CR2690","doi-asserted-by":"crossref","unstructured":"Harris HC et al. Impact of the source of fermentable carbohydrate on SCFA production by human gut microbiota in vitro \u2013 a systematic scoping review and secondary analysis. Crit Rev Food Sci Nutr. 2021;61(22):3892\u2013903","DOI":"10.1080\/10408398.2020.1809991"},{"key":"5739_CR2698","doi-asserted-by":"crossref","unstructured":"Schaus SR et al. Ruminococcus torques is a keystone degrader of intestinal mucin glycoprotein, releasing oligosaccharides used by Bacteroides thetaiotaomicron. mBio. 2024;15(8):e0003924","DOI":"10.1128\/mbio.00039-24"},{"key":"5739_CR2702","doi-asserted-by":"crossref","unstructured":"Tingler AM, Engevik MA. Breaking down barriers: is intestinal mucus degradation by Akkermansia muciniphila beneficial or harmful? Infect Immun. 2025;93(9):e0050324","DOI":"10.1128\/iai.00503-24"},{"key":"5739_CR2713","doi-asserted-by":"crossref","unstructured":"Parrish A et al. Akkermansia muciniphila exacerbates food allergy in fibre-deprived mice. Nat Microbiol. 2023;8(10):1863\u201379","DOI":"10.1038\/s41564-023-01464-1"},{"key":"5739_CR2721","doi-asserted-by":"crossref","unstructured":"Wang L et al. Gut microbial dysbiosis in the irritable bowel syndrome: a systematic review and meta-analysis of case-control studies. J Acad Nutr Diet. 2020;120(4):565\u201386","DOI":"10.1016\/j.jand.2019.05.015"},{"key":"5739_CR2729","doi-asserted-by":"crossref","unstructured":"Roka R et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol. 2007;5(5):550\u20135","DOI":"10.1016\/j.cgh.2006.12.004"},{"key":"5739_CR2733","doi-asserted-by":"crossref","unstructured":"Ghoshal U et al. Irritable bowel syndrome, particularly the constipation-predominant form, involves an increase in Methanobrevibacter smithii, which is associated with higher methane production. Gut Liver. 2016;10(6):932\u20138","DOI":"10.5009\/gnl15588"},{"key":"5739_CR2737","doi-asserted-by":"crossref","unstructured":"Piche T et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut. 2009;58(2):196\u2013201","DOI":"10.1136\/gut.2007.140806"},{"key":"5739_CR2741","doi-asserted-by":"crossref","unstructured":"Fritscher-Ravens A et al. Many patients with irritable bowel syndrome have atypical food allergies not associated with immunoglobulin E. Gastroenterology. 2019;157(1):109\u201318 e5","DOI":"10.1053\/j.gastro.2019.03.046"},{"key":"5739_CR2745","doi-asserted-by":"crossref","unstructured":"Aguilera-Lizarraga J et al. Local immune response to food antigens drives meal-induced abdominal pain. Nature. 2021;590(7844):151\u20136","DOI":"10.1038\/s41586-020-03118-2"},{"key":"5739_CR2751","doi-asserted-by":"crossref","unstructured":"Bar Yehuda S et al. The association of inflammatory bowel diseases with autoimmune disorders: a report from the epi-IIRN. J Crohns Colitis. 2019;13(3):324\u20139","DOI":"10.1093\/ecco-jcc\/jjy166"},{"key":"5739_CR2759","doi-asserted-by":"crossref","unstructured":"Mu Q et al. Leaky gut as a danger signal for autoimmune diseases. Front Immunol. 2017;8:598","DOI":"10.3389\/fimmu.2017.00598"},{"key":"5739_CR2763","doi-asserted-by":"crossref","unstructured":"Gupta A et al. Treat to target: The role of histologic healing in inflammatory bowel diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2021;19(9):1800\u201313 e4","DOI":"10.1016\/j.cgh.2020.09.046"},{"key":"5739_CR2769","doi-asserted-by":"crossref","unstructured":"Gibson GR et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat Rev Gastroenterol Hepatol. 2017;14(8):491\u2013502","DOI":"10.1038\/nrgastro.2017.75"},{"key":"5739_CR2779","doi-asserted-by":"crossref","unstructured":"Feng Y, et al. Short-chain fatty acids manifest stimulative and protective effects on intestinal barrier function through the inhibition of NLRP3 inflammasome and autophagy. Cell Physiol Biochem. 2018;49(1):190\u2013205","DOI":"10.1159\/000492853"},{"key":"5739_CR2787","doi-asserted-by":"crossref","unstructured":"Salminen S et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol. 2021;18(9):649\u201367","DOI":"10.1038\/s41575-021-00440-6"},{"key":"5739_CR2791","doi-asserted-by":"crossref","unstructured":"Rafique N et al. Promising bioactivities of postbiotics: A comprehensive review. J Agric Food Res. 2023;14:100708","DOI":"10.1016\/j.jafr.2023.100708"},{"key":"5739_CR2795","doi-asserted-by":"crossref","unstructured":"Wastyk HC et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137\u201353 e14","DOI":"10.1016\/j.cell.2021.06.019"},{"key":"5739_CR2800","doi-asserted-by":"crossref","unstructured":"Nielsen ES et al. Lacto-fermented sauerkraut improves symptoms in IBS patients independent of product pasteurisation \u2013 a pilot study. Food Funct. 2018;9(10):5323\u201335","DOI":"10.1039\/C8FO00968F"},{"key":"5739_CR2808","doi-asserted-by":"crossref","unstructured":"Caballero-Flores G et al. Microbiota-mediated colonization resistance: mechanisms and regulation. Nat Rev Microbiol. 2023;21(6):347\u201360","DOI":"10.1038\/s41579-022-00833-7"},{"key":"5739_CR2812","doi-asserted-by":"crossref","unstructured":"Recharla N et al. Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: a literature review. Nutrients. 2023;15(10):2275","DOI":"10.3390\/nu15102275"},{"key":"5739_CR2818","doi-asserted-by":"crossref","unstructured":"Madeo F et al. Nutritional aspects of spermidine. Annu Rev Nutr. 2020;40:135\u201359","DOI":"10.1146\/annurev-nutr-120419-015419"},{"key":"5739_CR2822","doi-asserted-by":"crossref","unstructured":"Ma L et al. Spermidine improves gut barrier integrity and gut microbiota function in diet- induced obese mice. Gut Microbes. 2020;12(1):1\u201319","DOI":"10.1080\/19490976.2020.1832857"},{"key":"5739_CR2826","doi-asserted-by":"crossref","unstructured":"Pi X et al. Recent advances in alleviating food allergenicity through fermentation. Crit Rev Food Sci Nutr. 2022;62(26):7255\u201368","DOI":"10.1080\/10408398.2021.1913093"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15006-026-5739-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-026-5739-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:01:40Z","timestamp":1776376900000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-026-5739-8"}},"subtitle":["Aktueller Wissensstand und klinische Perspektive"],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":43,"journal-issue":{"issue":"S3","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5739"],"URL":"https:\/\/doi.org\/10.1007\/s15006-026-5739-8","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"value":"1438-3276","type":"print"},{"value":"1613-3560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"17 April 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Prof. Dr. med. Martin Storr hat Beratungshonorare von MEDICE Arzneimittel P\u00fctter GmbH & Co. KG erhalten. Dr. med. Alina Burghard ist angestellt bei MEDICE Arzneimittel P\u00fctter GmbH & Co. KG.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die Arbeit wurde unterst\u00fctzt von der MEDICE Arzneimittel P\u00fctter GmbH & Co. KG, Iserlohn.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}